healthsystemCIO.com is the sole online-only publication dedicated to exclusively and comprehensively serving the information needs of healthcare CIOs.
“There aren’t many people who, in a moment’s notice, would drop everything and come help us if we needed it,” said Russ Branzell, President and CEO of CHIME, speaking about his friend, Tim Stettheimer. In a recent interview, Branzell talked about the enormous impact Stettheimer had on the industry, the qualities he embodied as a teacher and mentor, and the huge task CHIME faces in replacing him.
In this podcast interview, CHIME CEO Russ Branzell talks about the industry’s readiness to return to in-person events, how the organization is working to solve “the most difficult problems in healthcare,” even during Covid-19, and why recognizing heroes is so critical.
Forget silver linings. For CHIME, the “gold lining” of the Covid-19 pandemic is the fact that the organization was able to expand and “re-ground” while others were forced to retract, says CEO Russ Branzell.
Whether it’s through sharing best practices for reducing opioid prescriptions or building a more effective benchmarking program, the goal of every CHIME initiative is the same: to make an impact, says CEO Russ Branzell.
Before HIMSS kicked off, CHIME took an opportunity to recognize the achievements of those who are making an impact in healthcare IT, and encourage attendees to continue to push for change.
In comments submitted to CMS, CHIME expressed concern that Meaningful Use stage 3 is “too ambitious” and called for several key changes, including a 90-day reporting period for the first year of compliance. “With so few providers having demonstrated Stage 2 capabilities, we question the underlying feasibility of many requirements and question the logic of building […]
When CMS and ONC published the final rule last week granting additional flexibility for meeting Meaningful Use requirements in 2014, they failed to address a major issue, according to CHIME. The final rule will extend Stage 2 through 2016 for certain providers, and will push back Stage 3 until 2017. It will also grant providers […]
CHIME Speakers Bureau
Disappointment with ICD-10 delay — “Organizations literally were flipping switches as of that week.”
Working with AHIMA
Pushing for “reasonable flexibility” on MU 2
New membership groups
First-year success — “We were able to make some major ground in the industry.”
Reflecting on year one — “It’s been very exciting.”
“Jumping into the Washington fray”
CHIME as “the glue” that holds associations together
The 80/20 rule
Gaining momentum on patient matching
Boot Camp for CMIOs
CIO advisory boards
After several months of speculation — and requests from myriad organizations — it was announced Friday that the Meaningful Use Stage 2 deadline would be extended by one year. The move is intended to allow CMS and ONC to focus efforts on the successful implementation of the enhanced patient engagement, interoperability and HIE requirements in […]
